R

Reata Pharmaceuticals Inc
F:2R3

Watchlist Manager
Reata Pharmaceuticals Inc
F:2R3
Watchlist
Price: 161 EUR Market Closed
Market Cap: 6B EUR

Wall Street
Price Targets

2R3 Price Targets Summary
Reata Pharmaceuticals Inc

There are no price targets for 2R3.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Reata Pharmaceuticals Inc Competitors:
Price Targets
DPHARMA
Duopharma Biotech Bhd
35% Upside
216080
Jetema Co Ltd
40% Upside
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
14% Upside
DHG
Dhg Pharmaceutical Joint-Stock Co
18% Upside
13
HUTCHMED (China) Ltd
62% Upside
IRD
Opus Genetics Inc
297% Upside
WEED
Canopy Growth Corp
118% Upside

Revenue
Forecast

Revenue Estimate
Reata Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Reata Pharmaceuticals Inc's revenue is -33%.

-33%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Reata Pharmaceuticals Inc

Operating Income forecast
is not available for
Reata Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Reata Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 2R3's stock price target?
Not Available

2R3 doesn't have any price targets made by Wall Street professionals.

Back to Top